Resolving 340B noncompliance can be a time-consuming task for 340B participants — and one of the greatest challenges in managing a 340B program. This guide outlines the five steps to successfully navigate resolving compliance issues requiring repayment to manufacturers, from discovery to resolution, and includes a solution to help streamline the refund process.
With so many competing priorities dominating each workday, it can feel overwhelming to keep track of the latest developments that affect the 340B Program. There is a one-stop solution that 340B experts have used since 2019: the annual 340B Trends & Hot Topics module from the Apexus Advanced 340B Operations Certificate Program.
When it comes to operating a 340B program, health systems, hospitals, and other entities that participate in the federal drug pricing program administered by HRSA have found that hiring graduates of the Apexus Advanced 340B Operations Certificate Program is helping them achieve compliance and implement a successful 340B program.
Apexus is proud to be a corporate partner with the ASHP Foundation.
HRSA has developed a new 340B Administrative Dispute Resolution (ADR) process webpage.
Former Apexus PGY2 resident Ginikannwa Ezeude, PharmD share tips on navigating the Apexus residency experience virtually.
The ASHP Foundation today announced the appointment of Christopher A. Hatwig, R.Ph., M.S., FASHP, President of Apexus, LLC, to the ASHP Foundation Board of Directors as a Director at Large.
Join a panel of 340B certified experts on June 3, 2020 at noon CT for a webinar discussion of 340B operational considerations for telehealth, home infusion, and temporary sites during the COVID-19 pandemic.
Apexus, LLC, is pleased to announce it has been selected by the Health Resources & Services Administration (HRSA) to continue as the 340B Prime Vendor.
Former Apexus PGY2 administrative resident Minh Hoang, PharmD, MPH, shares her experiences, and lessons learned, from the Apexus 340B Operations Rotation.
Former Apexus 340B Operations Rotation resident Michael Peters, PharmD, BCPS, 340B ACE, shares valuable tips for residents preparing for the Apexus PGY2 health-system pharmacy administration rotation.
Coherus BioSciences, Inc., announced that the company has executed a 340B Prime Vendor Program contract agreement with Apexus, LLC for 340B hospitals and Q-Code issuance from the Centers for Medicare and Medicaid Services.
Find out more about what we do and how we can help you.
